Minerva Neurosciences, Inc.
NERV
$4.58
$0.6616.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 18.20M | 12.31M | 8.42M | 14.56M | 14.56M |
| Gross Profit | -18.20M | -12.31M | -8.42M | -14.56M | -14.56M |
| SG&A Expenses | 19.60M | 18.22M | 9.34M | 9.07M | 9.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.14M | 27.87M | 15.10M | 14.64M | 16.17M |
| Operating Income | -35.14M | -27.87M | -15.10M | -14.64M | -16.17M |
| Income Before Tax | -394.35M | -415.07M | -293.42M | -14.03M | 11.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -394.35 | -415.07 | -293.42 | -14.03 | 11.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -394.35M | -415.07M | -293.42M | -14.03M | 11.23M |
| EBIT | -35.14M | -27.87M | -15.10M | -14.64M | -16.17M |
| EBITDA | -35.13M | -27.87M | -15.10M | -14.64M | -16.16M |
| EPS Basic | -28.38 | -29.16 | -26.80 | -1.85 | 1.48 |
| Normalized Basic EPS | -17.72 | -18.23 | -16.75 | -1.16 | 0.93 |
| EPS Diluted | -28.87 | -29.16 | -26.80 | -1.85 | 1.48 |
| Normalized Diluted EPS | -17.82 | -18.23 | -16.75 | -1.16 | 0.93 |
| Average Basic Shares Outstanding | 109.19M | 70.16M | 33.83M | 30.28M | 30.28M |
| Average Diluted Shares Outstanding | 141.69M | 70.16M | 33.83M | 30.28M | 30.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |